Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
Arbutus Biopharma Corp reports 2021 executive compensation
By ExecPay News
Published: April 11, 2022
Arbutus Biopharma Corp reported fiscal year 2021 executive compensation information on April 11, 2022.
In 2021, three executives at Arbutus Biopharma Corp received on average a compensation package of $2.1M, a 24% increase compared to previous year.
Average pay of disclosed executives at Arbutus Biopharma Corp
William H. Collier, Chief Executive Officer, received $3.2M in total, which increased by 18% compared to 2020. 68% of Collier's compensation, or $2.2M, was in option awards. Collier also received $436K in non-equity incentive plan, $584K in salary, as well as $10K in other compensation.
Michael Sofia, Chief Scientific Officer, received a compensation package of $1.6M, which increased by 29% compared to previous year. 58% of the compensation package, or $939K, was in option awards.
David C. Hastings, Chief Financial Officer, earned $1.5M in 2021.
Related executives
You may also like
Source: SEC filing on April 11, 2022.